Status:

UNKNOWN

Pronase Granules in Gastric Cleaning

Lead Sponsor:

Changhai Hospital

Conditions:

Gastric Disease

Capsule Endoscopy

Eligibility:

All Genders

18-80 years

Phase:

PHASE2

PHASE3

Brief Summary

Magnetically controlled capsule endoscopy (MCE) is now widely used all over the world. However, the standard gastric preparation method by dimethicone we used clinically still has mucus at the bottom ...

Detailed Description

As a non-invasive and well-tolerated gastrointestinal examination method, magnetically controlled capsule endoscopy (MCE) is being increasingly used in different populations in recent years. Gastric p...

Eligibility Criteria

Inclusion

  • Age ≥ 18 years old.
  • Those who underwent upper gastrointestinal and small intestinal mucosal examination under magnetically controlled capsule endoscopy at Shanghai Changhai Hospital and Chinese People's Liberation Army General Hospital after January 2020.
  • Able to provide informed consent.

Exclusion

  • dysphagia or symptoms of gastric outlet obstruction, suspected or known intestinal stenosis, overt gastrointestinal bleeding, history of upper gastrointestinal surgery or abdominal surgery altering gastrointestinal anatomy, or post-abdominal radiation;
  • congestive heart failure, renal insufficiency, use of anticoagulant medication,
  • implanted metallic devices such as pacemakers, defibrillators, artificial heart valves or joint prostheses (although the low magnetic field used technically should not interfere with such devices);
  • pregnancy;
  • currently participating in another clinical study.
  • Patients who fail to follow the prescribed procedures for magnetically controlled capsule endoscopy;
  • Patients who only undergo gastric examination under magnetically controlled capsule endoscopy;
  • Patients who only undergo small bowel examination under magnetic control capsule endoscopy;
  • The patient's basic information in the database is incomplete#
  • Patient fail to be followed up.

Key Trial Info

Start Date :

February 24 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2022

Estimated Enrollment :

290 Patients enrolled

Trial Details

Trial ID

NCT05249933

Start Date

February 24 2021

End Date

March 1 2022

Last Update

February 22 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Changhai Hospital

Shanghai, Shanghai Municipality, China